Oppenheimer & Co’s Cognyte Software CGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25,312
Closed -$108K 1380
2022
Q2
$108K Sell
25,312
-40,486
-62% -$284K ﹤0.01% 1332
2022
Q1
$744K Sell
65,798
-10,072
-13% -$116K 0.01% 855
2021
Q4
$1.19M Sell
75,870
-8,550
-10% -$173K 0.02% 715
2021
Q3
$1.74M Buy
84,420
+3,145
+4% +$80.4K 0.03% 557
2021
Q2
$1.99M Buy
81,275
+11,746
+17% +$291K 0.04% 521
2021
Q1
$1.93M Buy
+69,529
New +$2.07M 0.04% 485

Other funds holding CGNT

Oppenheimer & Co's CGNT Position: Q3 2022 in Review

Oppenheimer & Co sold out of Cognyte Software (CGNT) in Q3 2022, closing a stake of 25,312 shares — an estimated $108K sold.

Oppenheimer & Co first reported a position in CGNT in Q1 2021 and held it in 6 quarters. The position peaked at $1.99M in Q2 2021. 124 funds tracked by Wall St. Rank hold CGNT as of Q3 2022.

  • Oppenheimer & Co reported no remaining Cognyte Software position as of Q3 2022 after selling out during the quarter.
  • Oppenheimer & Co sold 25,312 Cognyte Software shares in Q3 2022, an estimated $108K.
  • Oppenheimer & Co first reported a position in Cognyte Software in Q1 2021 and held it in 6 quarters.
  • Oppenheimer & Co's Cognyte Software position peaked at $1.99M in Q2 2021.
  • 124 funds tracked by Wall St. Rank held Cognyte Software as of Q3 2022.

Based on Oppenheimer & Co's 13F filing for Q3 2022, filed 14 Nov 2022.